At 7.5% CAGR, Asia Pacific Positive Airway Pressure (PAP) Devices Market is Projected to be Worth US$ 2,394.30 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Asia Pacific positive airway pressure (PAP) devices market was valued at US$ 1,341.04 million in 2023 and is expected to reach US$ 2,394.30 million by 2031, registering a CAGR of 7.5% from 2023 to 2031. Increasing awareness of respiratory diseases and growing shift toward home healthcare are among the critical factors attributed to the Asia Pacific positive airway pressure (PAP) devices market expansion.

More people are seeking medical attention for sleep problems as awareness grows. As a result, disorders such as OSA are being diagnosed more frequently and treated with machines that provide CPAP or BiPAP. Government and medical institutions frequently conduct public awareness campaigns for the risks of untreated sleep apnea leading to diabetes and cardiovascular problems. The need for PAP devices is rising due to the campaigns promoting early detection and treatment. Patients and healthcare professionals are paying more attention as the value of sleep health becomes more widely recognized. The market for PAP devices is growing as more people are taking initiatives to look for ways to enhance the quality of their sleep. For example, World Sleep Day was established in 2008 by the World Sleep Day Committee of the World Sleep Society. It is observed annually on the Friday before March Equinox. The event aims to celebrate the benefits of healthy sleep, raise awareness about the challenges associated with sleep-related issues, and promote the prevention and management of sleep disorders. Each year features a specific theme; for instance, in 2025, the theme will be "Make Sleep Health a Priority," which emphasizes the importance of prioritizing sleep for overall well-being.  To encourage people to monitor the quality of sleep, ResMed runs the "Awaken Your Best" campaign in South Asia and Latin America. ResMed hopes to raise awareness of sleep treatment and helpful tools for treating sleep disorders through this campaign. The sales of PAP devices are expected to rise significantly due to increasing awareness of COPD and other respiratory diseases. The Speak Up for COPD campaign is a global initiative focused on raising awareness and understanding of COPD among policymakers and healthcare decision-makers. Launched in 2021, the campaign aims to amplify the voices of patients, caregivers, and the wider COPD community to prioritize COPD as a critical public health issue. Thus, an increase in awareness of respiratory diseases is likely to create lucrative opportunities in the market.

On the contrary, product recall hampers the growth of Asia Pacific positive airway pressure (PAP) devices market.

Based on product type, the Asia Pacific positive airway pressure (PAP) devices market is segmented into automatic positive airway pressure (APAP) devices, continuous positive airway pressure (CPAP) devices, and bilevel positive airway pressure (BiPAP) devices. The continuous positive airway pressure (CPAP) devices segment held 68.3% share of the Asia Pacific positive airway pressure (PAP) devices market in 2023, amassing US$ 916.02 million. It is projected to garner US$ 1,758.99 million by 2031 to expand at 8.5% CAGR during 2023–2031.

Based on process or phase, the Asia Pacific positive airway pressure (PAP) devices market is segmented into chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea segment held 77.6% share of the Asia Pacific positive airway pressure (PAP) devices market in 2023, amassing US$ 1,040.85 million. It is projected to garner US$ 1,963.21 million by 2031 to expand at 8.3% CAGR during 2023–2031.

Based on end user, the Asia Pacific positive airway pressure (PAP) devices market is segmented into hospitals, ambulatory surgical centers, home care, and rehabilitation centers. The hospitals segment held 56.9% share of the Asia Pacific positive airway pressure (PAP) devices market in 2023, amassing US$ 763.69 million. It is projected to garner US$ 1,506.95 million by 2031 to expand at 8.9% CAGR during 2023–2031.

Based on country, the Asia Pacific positive airway pressure (PAP) devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 25.2% share of Asia Pacific positive airway pressure (PAP) devices market in 2023, amassing US$ 338.25 million. It is projected to garner US$ 690.65 million by 2031 to expand at 9.3% CAGR during 2023–2031.

Key players operating in the positive airway pressure (PAP) devices market are ICU Medical Inc; React Health (Formerly 3B Medical, Inc); Fisher & Paykel Healthcare Corp Ltd; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; Dragerwerk AG & Co KGaA; ResMed Inc; Vyaire Medical Inc; Wellell Inc; Armstrong Medical Ltd; Löwenstein Medical UK Ltd.; BMC Medical Co Ltd; and Narang Medical Limited., among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com